SCHEMBL10029583

SCHEMBL10029583

C[C@@H]1c2cc(O)c(O)cc2CCN1C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 1.00
DRD2 P14416 6/20 0.54
DRD4 P21917 2/20 0.54
DRD3 P35462 2/20 0.49
DRD1 P21728 3/20 0.48
HIF1A Q16665 2/20 0.48
HSD17B10 Q99714 2/20 0.48
MAPK1 P28482 1/20 0.48
THPO P40225 1/20 0.48
MTOR P42345 1/20 0.48
KDM4E B2RXH2 2/20 0.47
CYP2C9 P11712 1/20 0.47
TSHR P16473 1/20 0.47
MAPT P10636 1/20 0.47
BLM P54132 1/20 0.47
PMP22 Q01453 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25384852 1.00 MAOA (1.00) MAOADRD2DRD4DRD3DRD1
SCHEMBL8278403 1.00 MAOA (1.00) MAOADRD2DRD4DRD3DRD1
SCHEMBL14755354 0.88 MAOA (0.78) MAOADRD2DRD4DRD3DRD1
SCHEMBL8034415 0.84 MAOA (0.97) MAOADRD2DRD3DRD1HSD17B10
SCHEMBL14739491 0.84 MAOA (0.86) MAOADRD2DRD3DRD1MAPK1
SCHEMBL15161703 0.79 MAOA (0.66) MAOADRD2DRD4DRD1HSD17B10
SCHEMBL8032032 0.78 MAOA (0.64) MAOADRD2DRD4DRD3DRD1
SCHEMBL8032028 0.78 MAOA (0.64) MAOADRD2DRD1HSD17B10KDM4E
SCHEMBL8034457 0.78 MAOA (0.64) MAOADRD2DRD4HSD17B10MAPK1
SCHEMBL21444623 0.77 MAOA (0.63) MAOADRD2DRD4DRD3DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2694158-B1 SYSTEM AND DEVICE FOR ABLATION OF A VESSEL'S WALL FROM THE INSIDE MEDICAL DEVELOPMENT TECH S A (LU) 2018-12-19 EP claimed
US-20220238226-A1 METHOD FOR PREDICTING MEDICINAL EFFECTS OF COMPOUNDS USING DEEP LEARNING BIO-SYNERGY RESEARCH CENTER (KR) 2022-07-28 US disclosed
EP-2420237-A1 Fluorinated derivatives of endogenous isoquinolines for use in the treatment of diseases mediated through endogenous isoquinoline pathways Takio Ville (FI) 2012-02-22 EP disclosed